HIMSS Appoints Dr. April Zambelli-Weiner as HIMSS Public Policy Committee Member

Westminster, MD: On January 25, 2021, HIMSS appointed Dr. April Zambelli-Weiner, Founder & CEO of TTi Health Research & Economics, as a member of its Public Policy Committee. Dr. Zambelli-Weiner joins the ranks of public policy leaders working to effect change across various levels of government to reform the global health ecosystem.

HIMSS is a global advisor, thought leader, and member association committed to transforming the health ecosystem. As a mission-driven non-profit, HIMSS offers a unique depth and breadth of expertise in public policy, workforce development, research, and analytics to advise global leaders, stakeholders, and influencers on best practices.

The HIMSS Public Policy Committee convenes healthcare thought leaders across HIMSS membership, working closely with the HIMSS government relations team to advance global policy by collaborating with government officials around the world—including legislators, key national decision-makers, state and provincial leaders, and stakeholder organizations. The committee recommends policy positions on pending legislation and regulations, with the aim of reforming the global health ecosystem through the power of information and technology.

A noted expert in data creation across the healthcare ecosystem, Dr. Zambelli-Weiner is a sought-after advisor to executives and healthcare leaders on how data can be translated into evidence to solve particular challenges as they relate to informing health policy and practice. Dr. Zambelli-Weiner has led TTi into national health initiatives with government agencies such as CDC, overseeing and advancing health policy models; and has served as an SME and Senior Advisor on national studies of underserved and vulnerable populations. Since founding TTi in 2011 out of a desire to reduce silos in healthcare and speed the rate at which new research and technology are translated to policy and practice, she has helped bring to market and accelerate growth for hundreds of medical technology products including surgical instruments, capital equipment, diagnostics, precision medicine technologies, predictive algorithms, and disease management apps, among many others across a wide range of indication areas and use cases. Dr. Zambelli-Weiner holds a Ph.D. in Human Genetics & Epidemiology from Johns Hopkins University, an MPH in Epidemiology from Saint Louis University, and a BA in Chemistry and English from Washington & Jefferson College.

Dr. Zambelli-Weiner’s unique education, expertise in public policy, and advocacy, and ongoing commitment to transforming health information and technology to improve lives (human health) will help HIMSS to expand networking between peers and experts representing the global government sector, provide guidance on the best use of health information and technology, improve process and technologies within healthcare systems around the world, and advance educational opportunities and professional advancement, reforming the global health ecosystem through the power of information and technology.